Long-term response to recombinant human growth hormone treatment: a new predictive mathematical method

Authors:

Abstract
Recombinant GH has been offered to GH-deficient (GHD) subjects for more than 30 years, in order to improve height and growth velocity in children and to enhance metabolic effects in adults.

This publication has 29 references indexed in Scilit: